Sarepta Therapeutics Inc (OQ:SRPT)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for SRPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 20/19 Aug 20/19 Barry Richard Direct Ownership Common Stock P - Open market or private purchase 5,000 $99.32
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,625  
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -3,021  
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,863  
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 260 $13.71
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 985 $13.71
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,625 $13.90
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,021 $29.03
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -260  
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -985  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for SRPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 20/19 Aug 20/19 Barry Richard Direct Ownership Common Stock P - Open market or private purchase 5,000 $99.32
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,625  
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -3,021  
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,863  
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 260 $13.71
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 985 $13.71
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,625 $13.90
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,021 $29.03
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -260  
Aug 15/19 Aug 15/19 Mahatme Sandesh Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -985  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $SRPT

StockTwits